ADERIS PHARMACEUTICALS
Aderis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovery, development and commercialization of products for the diagnosis and treatment of cardio-renal diseases. Discovery Therapeutics' product pipeline includes adenosine agonists and antagonists for the diagnosis and treatment of cardiovascular disease and leukotriene synthesis inhibitors for the treatment of chronic renal disease. In addition the company has license agreements with strategic partners involving novel late stage products for the treatment of Parkinson's disease and diagnosis of coronary artery disease.
ADERIS PHARMACEUTICALS
Industry:
Biopharma Biotechnology Developer Platform Health Diagnostics
Founded:
1994-01-01
Address:
Richmond, Virginia, United States
Country:
United States
Website Url:
http://www.aderis.com
Total Employee:
11+
Status:
Active
Contact:
(804)358-9468
Email Addresses:
[email protected]
Total Funding:
45 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Nginx PHP PHP 7 Facebook Sharer Ubuntu
Similar Organizations
Investors List
China Development Industrial Bank (CDIB)
China Development Industrial Bank (CDIB) investment in Series D - Aderis Pharmaceuticals
Neomed Management
Neomed Management investment in Series D - Aderis Pharmaceuticals
International Biotechnology Trust
International Biotechnology Trust investment in Series D - Aderis Pharmaceuticals
Perseus-Soros Biopharmaceutical Fund
Perseus-Soros Biopharmaceutical Fund investment in Series D - Aderis Pharmaceuticals
Temasek Holdings
Temasek Holdings investment in Series D - Aderis Pharmaceuticals
Singapore Bio-Innovations
Singapore Bio-Innovations investment in Series D - Aderis Pharmaceuticals
Paladin Capital Group
Paladin Capital Group investment in Series D - Aderis Pharmaceuticals
MDS Capital
MDS Capital investment in Series D - Aderis Pharmaceuticals
Sanderling Ventures
Sanderling Ventures investment in Series D - Aderis Pharmaceuticals
Schroder Ventures
Schroder Ventures investment in Series D - Aderis Pharmaceuticals
Official Site Inspections
http://www.aderis.com
- Host name: 172.67.141.173
- IP address: 172.67.141.173
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
